リンビック・プレドミナント・アムネスティック・ニューロデジェネラティブ・シンドローム (LANS) の診断,病理学的特徴,および治療における新興概念:物語的レビュー
Macie A Serio1, Drew R Dethloff1, Grant C Curry1
1School of Medicine, Louisiana State University Health Sciences Center at Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA.
Advances in therapy
|August 29, 2025
まとめ
アルツハイマー病 (AD) と リンビック・ドミナント・アムネスティック・ニューロデジェネラティブ・シンドローム (LANS) を区別することは,効果的な認知症の治療に不可欠です. このレビューでは,AD,LANS,LATE-NCの病理学的違いを明らかにし,将来の治療法を指針にしています.
科学分野:
- 神経学
- 神経科学
- 病理学について
背景:
- 神経変性疾患は 神経系に進行的な損傷をもたらし 認知能力の回復不能な低下を招き 世界中で何百万もの患者に影響を及ぼします
- アルツハイマー病 (AD) とリンビックに優勢なアムネスティック神経変性症候群 (LANS) は,それぞれ認知症とアムネスティック症状の一般的な原因であり,類似点があるが,異なる病理学を持っています.
- これらの状態の正確な分類は,高齢化人口を管理するために不可欠です.
研究 の 目的:
- 神経変性疾患 (ND) の病理生理学,特にアルツハイマー病 (AD),辺縁性多発性アムネスティック神経変性症候群 (LANS),辺縁性多発性年齢関連TDP-43脳病 (LATE) を調査する.
- LANS 基準の必要性に関する調査結果をまとめます.
- LANSとADとLATEを臨床,画像,病理,バイオマーカー領域で比較する.
主な方法:
- 2024年11月までのデータベースを検索し,包括的な物語文献レビューが行われました.
- 主要な記事の参照リストも見直した.
- 研究設計,患者集団,神経病理学的発見,画像/バイオマーカー方法,および臨床的特徴に関するデータが抽出され,合成されました.
主要な成果:
- AD,LANS,LATEの主要な病理学的特徴と区別を,ピアレビューされた文献を用いて徹底的に分析した.
- これらの条件を複数の領域で比較した結果をまとめました.
結論:
- 最近提案されたLANSの臨床基準は 神経退行性疾患の特徴と治療における重要な進歩を表しています
- NDの微妙な病理生理学的違いを理解することは,標的型で病気を修正する治療法の開発に不可欠です.
- このレビューは,LATE-NC変化を含むADと他のNDの簡潔な比較を提供します.
関連する概念動画
01:15Functional Brain Systems: Limbic System
5.0K
The limbic system, often called the "emotional brain," is a complex set of structures located deep within the brain. The intricate network of the limbic system supports a wide range of psychological functions, from emotional regulation to memory formation and sensory processing. This functional brain region encompasses specific parts of the diencephalon and the cerebrum, integrating the higher mental functions of the cerebral cortex with the primitive emotional responses of the deep brain...
5.0K
01:26Alzheimer's Disease: Overview
1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
01:15Parkinson's Disease: Overview
1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
01:22Alzheimer's Disease: Treatment
565
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
565
01:30Dementia
285
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
285
01:13Amnesia
285
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
285